Influenza Virus and SARS-CoV-2 Vaccines | Zendy

Adam Sandor | Zendy; Michael Sturdivant | Zendy; Jenny P.Y. Ting | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Influenza Virus and SARS-CoV-2 Vaccines

Author(s) -

Adam Sandor,

Michael Sturdivant,

Jenny P.Y. Ting

Publication year - 2021

Publication title -

the journal of immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.737

H-Index - 372

eISSN - 1550-6606

pISSN - 0022-1767

DOI - 10.4049/jimmunol.2001287

Subject(s) - pandemic , virology , covid-19 , virus , looming , medicine , coronavirus , live attenuated influenza vaccine , influenza a virus , influenza vaccine , outbreak , infectious disease (medical specialty) , disease , pathology , physics , optics

Seasonal influenza and the current COVID-19 pandemic represent looming global health challenges. Efficacious and safe vaccines remain the frontline tools for mitigating both influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced diseases. This review will discuss the existing strategies for influenza vaccines and how these strategies have informed SARS-CoV-2 vaccines. It will also discuss new vaccine platforms and potential challenges for both viruses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research